Modifications of apoptosis-related protein levels in lymphocytes of patients with Parkinson's disease. The effect of dopaminergic treatment.
Blandini F, Cosentino M, Mangiagalli A, Marino F, Samuele A, Rasini E, Fancellu R, Tassorelli C, Pacchetti C, Martignoni E, Riboldazzi G, Calandrella D, Lecchini S, Frigo G, Nappi G.
Blandini F, et al. Among authors: riboldazzi g.
J Neural Transm (Vienna). 2004 Aug;111(8):1017-30. doi: 10.1007/s00702-004-0123-1. Epub 2004 Mar 19.
J Neural Transm (Vienna). 2004.
PMID: 15254790
Clinical Trial.